| CoQ10 | Coenzyme Q10 |
| ADI | Acceptable daily intake |
| NOAEL | No-observed-adverse-effect level |
| UVB | Ultraviolet B |
| CVD | Diabetic cardiovascular disease |
| ROS | Reactive oxygen species |
| RAGE | Receptor for advanced glycation end products |
| AGEs | Advanced glycation end products |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| PKC | Protein kinase C |
| DN | Diabetic nephropathy |
| UTMD | Ultrasound-targeted microbubble destruction |
| MSA | Multiple system atrophy |
| CSF | Cerebrospinal fluid |
| COQ2 | Coenzyme Q2 |
| COQ9 | Coenzyme Q9 |
| COQ8A | Coenzyme Q8A |
| ETFDH | Electron transfer flavoprotein dehydrogenase |
| PDSS2 | Decaprenyl diphosphate synthase subunit 2 |
| AIDS | Acquired immune deficiency syndrome |
| CRP | C-reactive protein |
| IL-6 | Interleukin 6 |
| TNF-α | Tumor necrosis factor alpha |
| P-gp | P-glycoprotein |
| TPGS | α-tocopherol polyethylene glycol 1000 succinate |
| RGC | Retinal ganglion cells |
| IOP | Intraocular pressure |
| PD | Parkinson disease |
| NF-β | Nuclear factor beta |
| POPC | Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine |
| IMM | Inner mitochondrial membrane |
| IIF | Flavin site in complex II |
| FM | Fibromyalgia |
| IL-1β | Interleukin 1 beta |
| UV | Ultraviolet |
| IL-18 | Interleukin 18 |
| FH | Familial hypercholesterolemia |
| GIT | Gastrointestinal tract |
| SNEDDS | Self-nanoemulsifying drug delivery systems |
| HPH | High-pressure homogenization |
| PHCO | PEG40 hydrogenated castor oil |
| TPGS | Tocopherol polyethylene glycol succinate |
| EC | Ethyl cellulose |
| MCT | Medium-chain triglyceride |
| SMS | SMS detergent |
| CMC | Critical micelle concentration |
| HMGCR | 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase |
| LDL | Low-density lipoprotein |
| LDL-R | Low-density lipoprotein receptor |
| ACE | Angiotensin-converting enzyme |
| CHF | Chronic heart failure |